|
|
|||
| |||||||||||||||||||||||||||||||||||
Once long-term treatment of end-stage renal disease (ESRD) became an entitlement under Medicare in 1972, a disorder that had usually been fatal was magically transformed into a chronic condition, but this transformation came with the enormous logistic problem of establishing the dialysis and kidney-transplantation facilities that now keep nearly 400,000 patients alive in the United States. Between 1968 and 1989, National Medical Care, a newly formed company, established the pattern of building and managing free-standing facilities for ambulatory dialysis a pattern that has been copied worldwide. In The Price of Access, Tim McFeeley, the former corporate counsel for National
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |